Tim Anderson Analyst Performance

Tim Anderson is a stock analyst at UBS Group in the medical sector, covering 13 publicly traded companies. Over the past year, Tim Anderson has issued 24 stock ratings, including buy, hold, and sell recommendations. While full access to Tim Anderson's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Tim Anderson's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Analyst Ranking

Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeat

Average Return

00.00% 12-Month ROI

Success Rate

00.00% Profitable Ratings

Total Ratings

29 Last 10 Years

Buy Recommendations

44.83% 13 Buy Ratings

Companies Covered

13 Unique Companies

Ratings Distribution

Rating	Percentage	Count
Strong Buy	0.0%	0 ratings
Buy	44.8%	13 ratings
Hold	34.5%	10 ratings
Sell	20.7%	6 ratings

Out of 29 total stock ratings issued by Tim Anderson at UBS Group, the majority (44.8%) have been Buy recommendations, followed by 34.5% Hold and 20.7% Sell.

Best & Worst Calls

• Best Call

  00.0%

  PFE

  Sep 2016

  Subscribe to MarketBeat All Access to get analyst recommendation ROI.
• Worst Call

  000.0%

  PFE

  Aug 2016

  Subscribe to MarketBeat All Access to get analyst recommendation ROI.

Exchange Coverage

Exchange	Percentage	Count
NASDAQ	53.8% of companies on NASDAQ	7 companies
NYSE	46.2% of companies on NYSE	6 companies

Tim Anderson, an analyst at UBS Group, currently covers 13 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.

Coverage Focus

Sector Icon	Sector	Percentage
	Medical 13 companies	100.0%

Tim Anderson of UBS Group specializes in stock coverage within the Medical sector.

Coverage Industries

Industry	Percentage
MED - BIOMED/GENE 8 companies	61.5%
LARGE CAP PHARMA 5 companies	38.5%

Tim Anderson's Ratings History at UBS Group

Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe

Start Date

End Date

All Ratings Strong Buy Buy Hold Sell Rating

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription

12-Month ROIUpgrade to All Access to use the All ROI Filter

Export to Excel

Company	Report Date	Action	Report Date Price	12-Month Price Target	Rating	12-Month Price & ROI	Details
PFE Pfizer	10/3/2025	Boost Price Target	$27.08	$30.00	Neutral	$0.00 00.00% ROI
JNJ Johnson & Johnson	10/3/2025	Boost Price Target	$187.73	$198.00	Neutral	$0.00 00.00% ROI
PFE Pfizer	10/1/2025	Reiterated Rating	$26.30	$28.00	Neutral	$0.00 00.00% ROI
AMGN Amgen	9/26/2025	Boost Price Target	$271.86	$272.00	Underperform	$0.00 00.00% ROI
MTSR Metsera	8/28/2025	Boost Price Target	$36.38	$50.00	Buy	$0.00 00.00% ROI
AARD Aardvark Therapeutics	8/28/2025	Lower Price Target	$8.64	$25.00	Buy	$0.00 00.00% ROI
APGE Apogee Therapeutics	8/28/2025	Boost Price Target	$36.98	$87.00	Buy	$0.00 00.00% ROI
PFE Pfizer	8/6/2025	Boost Price Target	$24.69	$28.00	Neutral	$0.00 00.00% ROI
AMGN Amgen	7/23/2025	Boost Price Target	$307.42	$261.00	Underperform	$0.00 00.00% ROI
JNJ Johnson & Johnson	7/17/2025	Boost Price Target	$164.78	$175.00	Neutral	$0.00 00.00% ROI
REGN Regeneron Pharmaceuticals	4/17/2025	Lower Price Target	$549.28	$547.00	Underperform	$0.00 00.00% ROI
JNJ Johnson & Johnson	4/10/2025	Lower Price Target	$149.02	$159.00	Neutral	$0.00 00.00% ROI
AARD Aardvark Therapeutics	3/27/2025	Boost Price Target	$10.38	$26.00	Buy	$0.00 00.00% ROI
AARD Aardvark Therapeutics	3/10/2025	Initiated Coverage	$10.13	$22.00	Buy	$0.00 00.00% ROI
JNJ Johnson & Johnson	3/5/2025	Boost Price Target	$164.67	$171.00	Neutral	$0.00 00.00% ROI
GILD Gilead Sciences	3/5/2025	Boost Price Target	$115.60	$126.00	Buy	$0.00 00.00% ROI
AMGN Amgen	3/5/2025	Boost Price Target	$315.78	$294.00	Underperform	$0.00 00.00% ROI
ABBV AbbVie	3/4/2025	Boost Price Target	$213.05	$223.00	Neutral	$0.00 00.00% ROI
MTSR Metsera	2/25/2025	Initiated Coverage	$29.81	$38.00	Buy	$0.00 00.00% ROI
MRNA Moderna	2/11/2025	Lower Price Target	$31.87	$34.00	Underperform	$0.00 00.00% ROI
AMGN Amgen	2/6/2025	Boost Price Target	$307.81	$275.00	Underperform	$0.00 00.00% ROI
MRK Merck & Co., Inc.	2/5/2025	Lower Price Target	$88.67	$112.00	Buy	$0.00 00.00% ROI
JNJ Johnson & Johnson	1/23/2025	Lower Price Target	$145.39	$159.00	Neutral	$0.00 00.00% ROI
JNJ Johnson & Johnson	1/17/2025	Lower Price Target	$147.26	$160.00	Neutral	$0.00 00.00% ROI

Stock Forecasts and Research Tools

Sign in to your free account to enjoy these benefits

• In-depth profiles and analysis for 20,000 public companies.
• Real-time analyst ratings, insider transactions, earnings data, and more.
• Our daily ratings and market update email newsletter.

Sign in to your free account to enjoy all that MarketBeat has to offer.

• Sign In
• Create Account

Your Email Address:

Email Address Required

Your Password:

Password Required

Log In

---

or

Sign in with Facebook Sign in with Google

Forgot your password?

Your Email Address:

Please enter your email address.

Please enter a valid email address

Choose a Password:

Please enter your password.

Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character.

Create My Account (Free)

---

or

Sign in with Facebook Sign in with Google

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.